Watchdog Group: Remove ALS Drug Relyvrio From Market Now

The watchdog group Public Citizen is calling for the prompt removal of the ALS drug Relyvrio after it failed to meet primary and secondary endpoints in top-line results from a phase 3 trial.

Related Keywords

Maryland ,United States ,Washington ,Phoenix ,Arizona ,Baltimore ,American ,Ceos Justin Klee ,Robert Steinbrook ,Caleb Alexander ,Joshua Cohen ,Amylyx Pharmaceuticals ,Drug Administration ,Public Citizen Health Research Group ,Central Nervous System Drugs Advisory Committee ,Public Citizen ,Medscape Medical News ,Justin Klee ,Health Research Group ,Johns Hopkins Bloomberg School ,Public Health Center ,Drug Safety ,Central Nervous System Drugs Advisory ,Medscape Medical ,Big Pharma ,